Micronized Itraconazole: Another Topical Choice for Fungal Sinus Infections

With many companies searching for the perfect solution for patients with Chronic Sinusitis, ASL Pharmacy (http://www.aslrx.com) is proposing an alternative medication choice for patients with fungus infections of the sinuses: Micronized Itraconazole delivered topically via nasal nebulization.

Camarillo, CA (PRWEB) May 26, 2008 -- ASL Pharmacy's Sinus Science (http://www.aslrx.com) program has observed positive results utilizing Itraconazole as an alternative to Amphotericin B for treating Allergic Fungal Sinus Infections. The benefits of our micronized formula may also be enhanced when proceeded by a corticosteroid.

1.Itraconazole Micronized Formulation

a)Our aerosolized suspension contains 40mg Itraconazole per 4ml volume (0.9% NaCl base)

b)Viable alternative when Amphotericin B is not covered by insurance or desired results are not achieved

c)Sealed in unit dose vials lab tested for 60 day stability

d)Minimal side effects: aerosolized Itraconazole is generally more tolerable than Amphotericin B

e)May be prepared with a surfactant ingredient

2.Dual Sequential Therapy

a)Sequential use of Mometasone or Betamethasone followed by Itraconazole appears to increase medication deposition and improve patient outcomes

b)Biofilm: ASL is currently compounding specific ingredients to be administered prior to an antibiotic (or antifungal) for the reduction of biofilm. Call for more details.

ASL's Sinus Science™ staff appreciates the opportunity to work with you and your patients. Please call to discuss your specific patient case with one of our pharmacists at 866-552-7579.

Russell Reitz, Pharm.D.                

###


Contact Information
Cal Tarrant
ASL Pharmacy
http://www.sinusscience.com
805-482-5555
Cal Tarrant
Sinus Science
http://www.aslrx.com
805-482-5555

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy